Bromodomain inhibitors and cancer therapy: From structures to applications

Montserrat Pérez-Salvia, Manel Esteller

Open source

DOI: 10.1080/15592294.2016.1265710
Published: 2017-02-16
Container: Epigenetics
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/15592294.2016.1265710,
  title = {Bromodomain inhibitors and cancer therapy: From structures to applications},
  author = {Montserrat Pérez-Salvia and Manel Esteller},
  year = {2017},
  journal = {Epigenetics},
  doi = {10.1080/15592294.2016.1265710},
  url = {https://doi.org/10.1080/15592294.2016.1265710}
}

RIS

TY  - JOUR
TI  - Bromodomain inhibitors and cancer therapy: From structures to applications
AU  - Montserrat Pérez-Salvia
AU  - Manel Esteller
PY  - 2017
JO  - Epigenetics
DO  - 10.1080/15592294.2016.1265710
UR  - https://doi.org/10.1080/15592294.2016.1265710
ER  -

APA

Pérez-Salvia, M., & Esteller, M. (2017). Bromodomain inhibitors and cancer therapy: From structures to applications. Epigenetics. https://doi.org/10.1080/15592294.2016.1265710

Source records

crossref · retrieved 2026-09-26T06:26:09.658Z